• Home >>
  • Pharmaceuticals and Healthcare

Covid-19 Impact on Induced Pluripotent Stem Cells Market, Global Research Reports 2020-2021

  • ID : 1240202
  • Date : 15 June 2020
  • Region : Global
  • Pages :90

CHOOSE LICENCE TYPE

This report covers market size and forecasts of Induced Pluripotent Stem Cells, including the following market information: Global Induced Pluripotent Stem Cells Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Induced Pluripotent Stem Cells Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Induced Pluripotent Stem Cells Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) Global Induced Pluripotent Stem Cells Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) Key market players Major competitors identified in this market include Fujifilm Holding Corporation, Astellas Pharma, Fate Therapeutics, Bristol-Myers Squibb Company, ViaCyte, Celgene Corporation, Aastrom Biosciences, Acelity Holdings, StemCells, Japan Tissue Engineering, Organogenesis, etc. Based on the Region: Asia-Pacific (China, Japan, South Korea, India and ASEAN) North America (US and Canada) Europe (Germany, France, UK and Italy) Rest of World (Latin America, Middle East & Africa) Based on the Type: Hepatocytes Fibroblasts Keratinocytes Amniotic Cells Others Based on the Application: Academic Research Drug Development And Discovery Toxicity Screening Regenerative Medicine

1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Induced Pluripotent Stem Cells Industry 1.7 COVID-19 Impact: Induced Pluripotent Stem Cells Market Trends 2 Global Induced Pluripotent Stem Cells Quarterly Market Size Analysis 2.1 Induced Pluripotent Stem Cells Business Impact Assessment - COVID-19 2.1.1 Global Induced Pluripotent Stem Cells Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Induced Pluripotent Stem Cells Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 By Players, Global Induced Pluripotent Stem Cells Quarterly Market Size, 2019 VS 2020 3.2 By Players, Induced Pluripotent Stem Cells Headquarters and Area Served 3.3 Date of Key Players Enter into Induced Pluripotent Stem Cells Market 3.4 Key Players Induced Pluripotent Stem Cells Product Offered 3.5 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Induced Pluripotent Stem Cells Segments, By Type 4.1 Introduction 1.4.1 Hepatocytes 1.4.2 Fibroblasts 1.4.3 Keratinocytes 1.4.4 Amniotic Cells 1.4.5 Others 4.2 By Type, Global Induced Pluripotent Stem Cells Market Size, 2019-2021 5 Impact of Covid-19 on Induced Pluripotent Stem Cells Segments, By Application 5.1 Overview 5.5.1 Academic Research 5.5.2 Drug Development And Discovery 5.5.3 Toxicity Screening 5.5.4 Regenerative Medicine 5.2 By Application, Global Induced Pluripotent Stem Cells Market Size, 2019-2021 5.2.1 By Application, Global Induced Pluripotent Stem Cells Market Size by Application, 2019-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Fujifilm Holding Corporation 7.1.1 Fujifilm Holding Corporation Business Overview 7.1.2 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.1.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Product Introduction 7.1.4 Fujifilm Holding Corporation Response to COVID-19 and Related Developments 7.2 Astellas Pharma 7.2.1 Astellas Pharma Business Overview 7.2.2 Astellas Pharma Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.2.3 Astellas Pharma Induced Pluripotent Stem Cells Product Introduction 7.2.4 Astellas Pharma Response to COVID-19 and Related Developments 7.3 Fate Therapeutics 7.3.1 Fate Therapeutics Business Overview 7.3.2 Fate Therapeutics Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.3.3 Fate Therapeutics Induced Pluripotent Stem Cells Product Introduction 7.3.4 Fate Therapeutics Response to COVID-19 and Related Developments 7.4 Bristol-Myers Squibb Company 7.4.1 Bristol-Myers Squibb Company Business Overview 7.4.2 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.4.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Product Introduction 7.4.4 Bristol-Myers Squibb Company Response to COVID-19 and Related Developments 7.5 ViaCyte 7.5.1 ViaCyte Business Overview 7.5.2 ViaCyte Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.5.3 ViaCyte Induced Pluripotent Stem Cells Product Introduction 7.5.4 ViaCyte Response to COVID-19 and Related Developments 7.6 Celgene Corporation 7.6.1 Celgene Corporation Business Overview 7.6.2 Celgene Corporation Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.6.3 Celgene Corporation Induced Pluripotent Stem Cells Product Introduction 7.6.4 Celgene Corporation Response to COVID-19 and Related Developments 7.7 Aastrom Biosciences 7.7.1 Aastrom Biosciences Business Overview 7.7.2 Aastrom Biosciences Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.7.3 Aastrom Biosciences Induced Pluripotent Stem Cells Product Introduction 7.7.4 Aastrom Biosciences Response to COVID-19 and Related Developments 7.8 Acelity Holdings 7.8.1 Acelity Holdings Business Overview 7.8.2 Acelity Holdings Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.8.3 Acelity Holdings Induced Pluripotent Stem Cells Product Introduction 7.8.4 Acelity Holdings Response to COVID-19 and Related Developments 7.9 StemCells 7.9.1 StemCells Business Overview 7.9.2 StemCells Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.9.3 StemCells Induced Pluripotent Stem Cells Product Introduction 7.9.4 StemCells Response to COVID-19 and Related Developments 7.10 Japan Tissue Engineering 7.10.1 Japan Tissue Engineering Business Overview 7.10.2 Japan Tissue Engineering Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.10.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Product Introduction 7.10.4 Japan Tissue Engineering Response to COVID-19 and Related Developments 7.11 Organogenesis 7.11.1 Organogenesis Business Overview 7.11.2 Organogenesis Induced Pluripotent Stem Cells Quarterly Revenue, 2020 7.11.3 Organogenesis Induced Pluripotent Stem Cells Product Introduction 7.11.4 Organogenesis Response to COVID-19 and Related Developments 8 Key Findings 9 Appendix 9.1 About US 9.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Induced Pluripotent Stem Cells Assessment Table 9. COVID-19 Impact: Induced Pluripotent Stem Cells Market Trends Table 10. COVID-19 Impact Global Induced Pluripotent Stem Cells Market Size Table 11. Global Induced Pluripotent Stem Cells Quarterly Market Size, 2020 (US$ Million) Table 12. Global Induced Pluripotent Stem Cells Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 13. Global Induced Pluripotent Stem Cells Market Growth Drivers Table 14. Global Induced Pluripotent Stem Cells Market Restraints Table 15. Global Induced Pluripotent Stem Cells Market Opportunities Table 16. Global Induced Pluripotent Stem Cells Market Challenges Table 17. By Players, Induced Pluripotent Stem Cells Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 18. Key Players, Induced Pluripotent Stem Cells Revenue Market Share, 2019 VS 2020 (%) Table 19. Key Induced Pluripotent Stem Cells Players Headquarters and Area Served Table 20. Date of Key Players Enter into Induced Pluripotent Stem Cells Market Table 21. Key Players Induced Pluripotent Stem Cells Product Type Table 22. Mergers & Acquisitions, Expansion Plans Table 23. By Players, Global Induced Pluripotent Stem Cells Market Size 2019-2021, (US$ Million) Table 24. Global Induced Pluripotent Stem Cells Market Size by Application: 2019-2021 (US$ Million) Table 25. Global Induced Pluripotent Stem Cells Market Size by Region, 2019-2021 (US$ Million) Table 26. By Country, North America Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 27. By Type, US Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 28. By Application, US Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 29. By Type, Canada Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 30. By Application, Canada Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 32. By Country, Europe Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 33. By Type, Germany Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 34. By Application, Germany Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 35. By Type, France Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 36. By Application, France Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 37. By Type, UK Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 38. By Application, UK Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 39. By Type, Italy Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 40. By Application, Italy Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 42. By Region, Asia-Pacific Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 43. By Type, China Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 44. By Application, China Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 45. By Type, Japan Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 46. By Application, Japan Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 47. By Type, South Korea Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 48. By Application, South Korea Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 49. By Type, India Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 50. By Application, India Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 51. By Type, ASEAN Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 52. By Application, ASEAN Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 53. By Type, Latin America Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 54. By Application, Latin America Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 55. By Type, Middle East and Africa Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 56. By Application, Middle East and Africa Induced Pluripotent Stem Cells Market Size, 2019-2021 (US$ Million) Table 57. Fujifilm Holding Corporation Business Overview Table 58. Fujifilm Holding Corporation Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Fujifilm Holding Corporation Induced Pluripotent Stem Cells Product Table 60. Fujifilm Holding Corporation Response to COVID-19 and Related Developments Table 61. Astellas Pharma Business Overview Table 62. Astellas Pharma Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Astellas Pharma Induced Pluripotent Stem Cells Product Table 64. Astellas Pharma Response to COVID-19 and Related Developments Table 65. Fate Therapeutics Business Overview Table 66. Fate Therapeutics Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Fate Therapeutics Induced Pluripotent Stem Cells Product Table 68. Fate Therapeutics Response to COVID-19 and Related Developments Table 69. Bristol-Myers Squibb Company Business Overview Table 70. Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Product Table 72. Bristol-Myers Squibb Company Response to COVID-19 and Related Developments Table 73. ViaCyte Business Overview Table 74. ViaCyte Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. ViaCyte Induced Pluripotent Stem Cells Product Table 76. ViaCyte Response to COVID-19 and Related Developments Table 77. Celgene Corporation Business Overview Table 78. Celgene Corporation Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Celgene Corporation Induced Pluripotent Stem Cells Product Table 80. Celgene Corporation Response to COVID-19 and Related Developments Table 81. Aastrom Biosciences Business Overview Table 82. Aastrom Biosciences Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Aastrom Biosciences Induced Pluripotent Stem Cells Product Table 84. Aastrom Biosciences Response to COVID-19 and Related Developments Table 85. Acelity Holdings Business Overview Table 86. Acelity Holdings Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Acelity Holdings Induced Pluripotent Stem Cells Product Table 88. Acelity Holdings Response to COVID-19 and Related Developments Table 89. StemCells Business Overview Table 90. StemCells Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. StemCells Induced Pluripotent Stem Cells Product Table 92. StemCells Response to COVID-19 and Related Developments Table 93. Japan Tissue Engineering Business Overview Table 94. Japan Tissue Engineering Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Japan Tissue Engineering Induced Pluripotent Stem Cells Product Table 96. Japan Tissue Engineering Response to COVID-19 and Related Developments Table 97. Organogenesis Business Overview Table 98. Organogenesis Induced Pluripotent Stem Cells Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Organogenesis Induced Pluripotent Stem Cells Product Table 100. Organogenesis Response to COVID-19 and Related Developments List of Figures Figure 1. Induced Pluripotent Stem Cells Product Picture Figure 2. Induced Pluripotent Stem Cells Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Induced Pluripotent Stem Cells Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Induced Pluripotent Stem Cells Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Induced Pluripotent Stem Cells Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Induced Pluripotent Stem Cells Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Induced Pluripotent Stem Cells Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Induced Pluripotent Stem Cells Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Induced Pluripotent Stem Cells Market Size Market Share, 2019-2021

CHOOSE LICENCE TYPE

TESTIMONIALS

What amazed me most was the professionalism and client satisfaction provided by Garner Insights. Their responses were quick and actioned on immediately.

Sr. Manager
A UK based manufacturing firm

I would like to thank the team at Garner Insights, you guys made my job so easier with your spoon fed service and quality market study.

President
At a US based consulting firm

The team of Garner Insights solved my queries in a timely fashion and gracefully. I have purchased reports from them a few times now and they never cease to impress with their highly intellectual team.

Marketing Manager
At a Fortune 100 pharmaceutical firm

I had some issues with the payment gateway and almost the immediate second I get a call from one of the enthusiastic sales member who guided me throughout the process and also reassured me of the next steps.

A Consultant
At a German based retail firm

The quality of data encompassed in the report was very useful for me in my marketing strategy needs

Director of Marketing
At a US based Manufacturing firm

What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

To request a free sample copy of this report, please complete the form below.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Check discount for this report, please complete the form below.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology